Share:
Peer-Reviewed Publication
Bioengineering (Basel)2024;11(5)May 7, 2024Journal Article

MurSS: A Multi-Resolution Selective Segmentation Model for Breast Cancer.

Joonho Lee1, Geongyu Lee1, Tae-Yeong Kwak1, Sun Woo Kim1, Min-Sun Jin2, Chungyeul Kim3, Hyeyoon Chang1
1Deep Bio Inc., Seoul 08380, Republic of Korea.
2Department of Pathology, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 14647, Republic of Korea.
3Department of Pathology, Korea University Guro Hospital, Seoul 08308, Republic of Korea.

Abstract

Accurately segmenting cancer lesions is essential for effective personalized treatment and enhanced patient outcomes. We propose a multi-resolution selective segmentation (MurSS) model to accurately segment breast cancer lesions from hematoxylin and eosin (H&E) stained whole-slide images (WSIs). We used The Cancer Genome Atlas breast invasive carcinoma (BRCA) public dataset for training and valida…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.